Trial
NCT03870529
High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
National Cancer Institute (NCI)
Condition
Non Small Cell Lung Cancer
Intervention
Vitamin A Compound
Why stopped
Slow accruals
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-09